DMK Pharma Sues Drug Co. It Claims Helped Drive It To Ch. 11
Drug developer DMK Pharmaceuticals has asked a Delaware bankruptcy judge to award it $328.7 million from pharmaceutical company US WorldMeds LLC, saying USWM didn't properly market an opioid-overdose intervention product, resulting...To view the full article, register now.
Already a subscriber? Click here to view full article